FAST & FLEXIBLE CE-IVD MARKED IMMUNOASSAY ANALYZER FOR RAPID PATIENT TESTING

SuperFlex Automated Chemiluminescence Analyzer

The SuperFlex Automated Chemiluminescence Analyzer is CE-IVD marked and intended for in vitro diagnostic use.  It delivers ultra-sensitive detection of small biological molecules using labeled antibodies and antigens in serum, plasma and whole blood. Twelve independent channels allow it to process up to twelve samples separately or simultaneously. With hands-free processing of samples, up to 48 samples to be processed per hour with 15-minute assays.

  • Fast – analyze 1-12 samples in 15 minutes
  • Hands-free processing – of up to 24 samples per run
  • Automatic sampling and one-click operation – reduce the risk of laboratory acquired infections

The automated barcode scanner incorporated into the SuperFlex Automated Chemiluminescence Analyzer ensures sample process traceability and adjustable sample detection priority reduces turnaround time for critical samples.

With one-click operation and a color touchscreen, the SuperFlex Automated Chemiluminescence Analyzer is easy to use. The system has a low failure rate and is easy to maintain. Remote monitoring notifies users of errors should they occur.

SuperFlex™ Chemiluminescent Immunoassay System

Products may not be licensed in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability.

Download Manual

Learn about the advantages the random-access SuperFlex™ Automated Chemiluminescence Analyzer offers which can simplify your immunoassay analysis

Fast, Automated POC Analysis

This POC chemiluminescent immunoassay analyzer delivers fast detection of:

  • Myo, CKMB, cTnI
  • NT-proBNP
  • PCT, CRP
  • Anti-SARS-CoV-2 IgG
  • Anti-SARS-CoV-2 Ab

When used with the SuperFlex™ Anti-SARS-CoV-2 IgG kit, each 12-sample batch can be run in only 15 minutes, allowing up to 48 samples to be processed per hour.

SuperFlex Automated Chemiluminescence Analyzer Citations

Ai, J., Zhang, H., Zhang, Q., Zhang, Y., Lin, K., Fu, Z., Song, J., Zhao, Y., Fan, M., Wang, H., Qiu, C., Zhou, Y., & Zhang, W. (2021). Recombinant protein subunit vaccine booster following two-dose inactivated vaccines dramatically enhanced anti-RBD responses and neutralizing titers against SARS-COV-2 and variants of concern. Cell Research, 32(1), 103–106. https://doi.org/10.1038/s41422-021-00590-x

Feng, Y., Zhang, Y., He, Z., Huang, H., Tian, X., Wang, G., Chen, D., Ren, Y., Jia, L., Wang, W., Wu, J., Shao, L., Zhang, W., Tang, H., & Wan, Y. (2022). Immunogenicity of an inactivated SARS-COV-2 vaccine in people living with HIV-1: A non-randomized cohort study. EClinicalMedicine, 43, 101226. https://doi.org/10.1016/j.eclinm.2021.101226

Zhang, R., Hong, Y., Shi, J., Zhao, R., Song, Y., Li, Z., & Wang, Q. (2021). Analytical Characterization and Clinical Performance Evaluation of a new point-of-care testing system for high-sensitivity cardiac troponin I assay. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 58(6), 579–585. https://doi.org/10.1177/00045632211027604

Contact us to automate your detection of sars-cov-2 antibodies
Products may not be licensed in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability.